Despite its potential, cancer genomics faces several challenges:
Genetic heterogeneity: Cancer is a highly heterogeneous disease, with significant genetic variation between and within tumors, complicating the identification of universal biomarkers. Data interpretation: The massive amount of data generated by genomic studies requires sophisticated bioinformatics tools and expertise to interpret meaningfully. Ethical considerations: Issues such as genetic privacy, informed consent, and the potential for genetic discrimination need to be carefully managed.
